Nutritional monitoring is critical in post-bariatric patients receiving GLP-1 receptor agonists, as both surgery and medication-induced reduced intake can compound deficiency risks
p25 induces the hyperactivation of cyclin-dependent kinase 5 and disrupts GSK3-mediated processes [67]
(30, 31) However, they also highlight potential cardiovascular and renal risks, emphasizing the need for careful perioperative monitoring and patient selection
Whether you are experiencing a frustrating decline in libido, a surprising increase in desire, or just want to understand what might happen before starting treatment, the information here draws from clinical research, case reports, neurochemistry, and the lived experiences of thousands of women navigating this exact question
The first GLP-1 receptor agonist, exenatide (Byetta), received U.S